USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
PHARMACOPHOTONICS, LLC
Address:
351 W. 10th St.
INDIANAPOLIS, IN 46202-
Phone:
N/A
URL:
N/A
EIN:
120582396
DUNS:
787934012
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,218,534.00 1
STTR Phase I $103,740.00 1
STTR Phase II $999,981.00 1

Award List:

Non-Invasive Optical Determination of GFR

Award Year / Program / Phase:
2008 / STTR / Phase I
Award Amount:
$103,740.00
Agency:
HHS
Principal Investigator:
Research Institution:
N/A
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): PharmacoPhotonics, LLC proposes research leading to a novel 2-photon in vivo fluorescence method for monitoring glomerular filtration rate (GFR) in acute kidney injury (AKI). AKI remains a vexing clinical problem result ing in unacceptably high patient mortality,… More

Non-Invasive Optical Determination of GFR

Award Year / Program / Phase:
2009 / STTR / Phase II
Award Amount:
$999,981.00
Agency:
HHS
Principal Investigator:
Research Institution:
INDIANA UNIVERSITY
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): PharmacoPhotonics (FAST Diagnostics), LLC proposes research to extend the Phase I STTR leading to a novel 2-photon in vivo fluorescence method for monitoring glomerular filtration rate (GFR) in acute kidney injury (AKI) . AKI remains a vexing clinical problem… More

Clinical Trial of the FAST Real-Time GFR System

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$1,218,534.00
Agency:
HHS
Principal Investigator:
Daniel Meier – 414-259-2097
Abstract:
DESCRIPTION (provided by applicant): PharmacoPhotonics (DBA FAST, Inc.) proposes Fast-Track research to determine GFR in its first human Pilot study. The long-term goal of this SBIR project is to test FAST's minimally invasive catheter based fluorescent device in humans and commercialize this… More